cas 2689-69-2|| where to buy Methyl 3-oxotetrahydrothiophene-2-carboxylate

製品名:Methyl 3-oxotetrahydrothiophene-2-carboxylate

IUPAC Name:methyl 3-oxothiolane-2-carboxylate

包装単位	有効在庫	価格（USD）
CM199155-1g	in stock	ŪŪ
CM199155-5g	in stock	ƚȤȅ
CM199155-10g	in stock	ƴŸȖ

研究開発用専用.

問い合わせフォーム

化学物質名

CAS番号

数量*

要求仕様*
（アッセイ %、材料グレード等）

お名前*

連絡先Eメールアドレス*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2689-69-2 regularly via the above email.

追記事項

Verification code*

refresh

: CAS番号:2689-69-2; 分子式:C6H8O3S; 融点:-; SMILESコード:COC(=O)C1SCCC1=O; 密度:

: カタログ番号:CM199155; 分子量:160.19; 沸点:248.4°C at 760 mmHg; MDL番号:MFCD00156156; 保管方法:Keep in dark place, store at 2-8°C.

: Tetrahydrothiophenes; Tetrahydrothiophene is a sulfur-containing saturated heterocyclic compound obtained by catalytic hydrogenation of thiophene. After thiophene is reduced to tetrahydrothiophene, it no longer has a conjugated system and aromaticity. Therefore, tetrahydrothiophene shows the properties of general thioethers. Easily oxidized to sulfoxides and sulfones. Tetrahydrothiophene can be used as a raw material for the production of pharmaceuticals, pesticides and photochemicals.

: Nerandomilast; Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study.
Nerandomilast (BI 1015550) is an investigational oral, preferential inhibitor of phosphodiesterase 4B (PDE4B) that is being studied as a potential treatment for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF). This compound is an investigational agent and has not been approved for use. Nerandomilast was granted FDA Breakthrough Therapy Designation for the treatment of IPF in February 2022.